Two Sigma Advisers’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
Two Sigma Advisers's NEO Position: Q1 2026 in Review
Two Sigma Advisers sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 83,600 shares — an estimated $983K sold.
Two Sigma Advisers first reported a position in NEO in Q3 2014 and held it in 17 quarters. The position peaked at $11.3M in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Two Sigma Advisers reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 83,600 NeoGenomics shares in Q1 2026, an estimated $983K.
- Two Sigma Advisers first reported a position in NeoGenomics in Q3 2014 and held it in 17 quarters.
- Two Sigma Advisers's NeoGenomics position peaked at $11.3M in Q1 2023.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.